Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


27.08.2018

1 Am J Pathol
1 Biochem Biophys Res Commun
4 BMC Cancer
2 BMC Gastroenterol
1 Cancer Res
1 Dig Dis Sci
1 Eur Radiol
4 Gastroenterology
4 Hepatology
1 Indian J Gastroenterol
1 Int J Cancer
6 J Hepatol
1 Proc Natl Acad Sci U S A
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. KORAL K, Haynes M, Bowen WC, Orr A, et al
    Lymphocyte-Specific Protein-1 Controls Sorafenib Sensitivity and Hepatocellular Proliferation through Extracellular Signal-Regulated Kinase 1/2 Activation.
    Am J Pathol. 2018;188:2074-2086.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. MA YL, Xia JL, Gao X
    Suppressing Irf2bp2 expressions accelerates metabolic syndrome-associated brain injury and hepatic dyslipidemia.
    Biochem Biophys Res Commun. 2018 Aug 18. pii: S0006-291X(18)31591.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. OZAKI Y, Shindoh J, Gonoi W, Nishioka Y, et al
    Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.
    BMC Cancer. 2018;18:138.
    PubMed     Text format     Abstract available

  4. MOHKAM K, Rayar M, Adam JP, Muscari F, et al
    Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT).
    BMC Cancer. 2018;18:844.
    PubMed     Text format     Abstract available

  5. PROMTHET S, Songserm N, Woradet S, Pientong C, et al
    Opisthorchiasis with proinflammatory cytokines (IL-1beta and TNF-alpha) polymorphisms influence risk of intrahepatic cholangiocarcinoma in Thailand: a nested case-control study.
    BMC Cancer. 2018;18:846.
    PubMed     Text format     Abstract available

  6. YU JJ, Xiao W, Dong SL, Liang HF, et al
    Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma.
    BMC Cancer. 2018;18:835.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  7. SARAGAI Y, Takaki A, Umeda Y, Matsusaki T, et al
    A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation.
    BMC Gastroenterol. 2018;18:62.
    PubMed     Text format     Abstract available

  8. DHAR A, Sadiq F, Anstee QM, Levene AP, et al
    Thrombin and factor Xa link the coagulation system with liver fibrosis.
    BMC Gastroenterol. 2018;18:60.
    PubMed     Text format     Abstract available


    Cancer Res

  9. GU L, Zhu Y, Lin X, Li Y, et al
    Amplification of glyceronephosphate O-acyltransferase and recruitment of USP30 stabilize DRP1 to promote hepatocarcinogenesis.
    Cancer Res. 2018 Aug 24. pii: 0008-5472.CAN-18-0340.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  10. ZHANG G, Yu X, Liu P, Huang X, et al
    Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
    Dig Dis Sci. 2018 Aug 23. pii: 10.1007/s10620-018-5252.
    PubMed     Text format     Abstract available


    Eur Radiol

  11. TANAKA T, Masada T, Nishiofuku H, Fukuoka Y, et al
    Development of pumping emulsification device with glass membrane to form ideal lipiodol emulsion in transarterial chemoembolization.
    Eur Radiol. 2018;28:2203-2207.
    PubMed     Text format     Abstract available


    Gastroenterology

  12. KLEBER G, Sauerbruch T
    Concomitant gastric varices: Bleeding risk sign in patients with liver cirrhosis and esophageal varices?
    Gastroenterology. 2018 Aug 21. pii: S0016-5085(18)34879.
    PubMed     Text format    

  13. BOYER A, Park SB, de Boer Y, Li Q, et al
    TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34892.
    PubMed     Text format     Abstract available

  14. MOREAU R, Elkrief L, Bureau C, Perarnau JM, et al
    Effects of Long-term Norfloxacin Therapy in Patients with Advanced Cirrhosis.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34891.
    PubMed     Text format     Abstract available

  15. KANWAL F, Kramer JR, Mapakshi S, Natarajan Y, et al
    Risk of Hepatocellular Cancer in Patients with Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34889.
    PubMed     Text format     Abstract available


    Hepatology

  16. HLADY RA, Sathyanarayan A, Thompson JJ, Zhou D, et al
    Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma.
    Hepatology. 2018 Aug 22. doi: 10.1002/hep.30211.
    PubMed     Text format     Abstract available

  17. LIGAT G, Schuster C, Baumert TF
    HBV core variants, liver fibrosis and hepatocellular carcinoma.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30231.
    PubMed     Text format     Abstract available

  18. ALLEGRETTI AS, Parada XV, Ortiz GA, Long J, et al
    Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30230.
    PubMed     Text format     Abstract available

  19. MARETTI-MIRA AC, Wang X, Wang L, DeLeve LD, et al
    Incomplete differentiation of engrafted bone marrow endothelial progenitor cells initiates hepatic fibrosis in the rat.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30227.
    PubMed     Text format     Abstract available


    Indian J Gastroenterol

  20. JHA SK, Mishra M, Jha A, Dayal VM, et al
    Comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial.
    Indian J Gastroenterol. 2018 Aug 21. pii: 10.1007/s12664-018-0871.
    PubMed     Text format     Abstract available


    Int J Cancer

  21. MARTINEZ-CARDONA C, Lozano-Ruiz B, Bachiller V, Peiro G, et al
    AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.
    Int J Cancer. 2018 Aug 22. doi: 10.1002/ijc.31827.
    PubMed     Text format     Abstract available


    J Hepatol

  22. SOLA E, Sole C, Simon-Talero M, Martin-Llahi M, et al
    MIDODRINE &ALBUMIN for Preventing COMPLICATIONS IN PATIENTS WITH CIRRHOSIS AWAITING Liver transplantation.
    J Hepatol. 2018 Aug 20. pii: S0168-8278(18)32285.
    PubMed     Text format     Abstract available

  23. IOANNOU GN, Green PK, Beste LA, Mun EJ, et al
    Development of Models Estimating the Risk of Hepatocellular Carcinoma After Antiviral Treatment for Hepatitis C.
    J Hepatol. 2018 Aug 20. pii: S0168-8278(18)32287.
    PubMed     Text format     Abstract available

  24. CLARK VC, Marek G, Liu C, Collinsworth A, et al
    Clinical and Histologic Features of Adults with Alpha-1 Antitrypsin Deficiency in a Non-Cirrhotic Cohort.
    J Hepatol. 2018 Aug 20. pii: S0168-8278(18)32284.
    PubMed     Text format     Abstract available

  25. ANDRADE F, Shukla A, Bureau C, Senzolo M, et al
    Pregnancy in Idiopathic Non-Cirrhotic Portal Hypertension: A Multicentric Study on Maternal and Fetal Management and Outcome.
    J Hepatol. 2018 Aug 20. pii: S0168-8278(18)32286.
    PubMed     Text format     Abstract available

  26. MOREAU R, Bataller R, Berg T, Lotersztajn S, et al
    Corrigendum to "From the Editor's Desk August 2018" [J Hepatol 69 (2018) 265-268].
    J Hepatol. 2018 Aug 21. pii: S0168-8278(18)32281.
    PubMed     Text format    

  27. YOUNOSSI Z, Stepanova M, Sanyal AJ, Harrison SA, et al
    The Conundrum of Cryptogenic Cirrhosis: Adverse Outcomes without Treatment Options.
    J Hepatol. 2018 Aug 22. pii: S0168-8278(18)32295.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  28. BUGIDE S, Green MR, Wajapeyee N
    Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells.
    Proc Natl Acad Sci U S A. 2018;115:E3509-E3518.
    PubMed     Text format     Abstract available


    Radiology

  29. PANDEY A, Pandey P, Ghasabeh MA, Zarghampour M, et al
    Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
    Radiology. 2018 Aug 21:180450. doi: 10.1148/radiol.2018180450.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: